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Abstract The cognitive style of rumination extends
existing cognitive models of emotional response to illness.
In the absence of a specific measure, we developed the
Multidimensional Rumination in Illness Scale (MRIS). In
Study 1, an initial 60-item pool was tested, followed by
confirmation of the factor structure in Study 2. In Study 1
participants (n = 185) completed the pilot version of the
MRIS, then in Study 2 (n = 163) a reduced 41-item model
was tested. Study 1: Exploratory factor analysis of a
reduced 32-item scale indicated an initial four-factor
solution for the MRIS (Intrusion, Brooding, Instrumental,
Preventability), with satisfactory internal consistency and
stable factor structure across gender. Study 2: Following
scale revision, confirmatory factor analysis substantiated
the adequacy of a three-factor MRIS structure, and good
internal consistency, test-rest reliability, and concurrent
and discriminant validity was demonstrated for the MRIS.
The MRIS exhibited good psychometric properties in the
current sample, providing a comprehensive assessment of
the cognitive style of rumination in the context of physical
illness.
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Introduction
Physical illness not only impacts an individual’s physical
functioning, but also psychological and social functioning
(Talbot and Nouwen, 2000). Elevated levels of depression
and anxiety are common sequelae of physical illness
(Ciechanowski et al., 2000; Street, 2003). Much of the
research concerning factors underlying these psychological
outcomes has focused on the role of cognitive content,
specifically maladaptive cognitive patterns around themes
of personal threat, vulnerability and hopelessness (Alloy
et al., 2000; Beck, 1967, 1976). However, more recently,
attention has moved towards the cognitive style of rumi-
nation, a repetitive style of thinking, and its role in the
aetiology and maintenance of depression and anxiety
(Lyubomirsky and Nolen-Hoeksema, 1993, 1995; Nolen-
Hoeksema, 1991a). While research largely focuses on
physically healthy populations, evidence suggests rumina-
tion may be important in adjustment to physical illness
(Cordova et al., 1995; Sears et al., 2003).
Rumination can be a means of coming to terms with
physical illness (Brosschot et al., 2006; Tedeschi and Cal-
houn, 2004), by thinking about the diagnosis itself, the
thoughts and feelings it evokes, and its implications (Bower
et al., 1998; Greenberg, 1995). However, the specific role of
rumination in adjustment to illness is unclear. Some evi-
dence links rumination to the onset and maintenance of
psychological distress (Nolen-Hoeksema and Morrow,
1991; Nolen-Hoeksema et al., 1994), while other evidence
suggests a link to perceived positive growth (Calhoun et al.,
2000). This differential effect of rumination may be
explained by the Martin and Tesser (1989) framework,
delineating 12 subclasses of rumination, each discriminated
by the emotional valence of ruminative thoughts, temporal
orientation and relation to a sense of discrepancy or goal.
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Physical illness can force a re-evaluation of life goals, which
may result in a disparity between ideal self as ‘healthy’ and
‘real self’, as affected by illness. The consequences of
rumination as a ‘sense-making’ process may therefore lead
to constructive or unconstructive outcomes, depending on
whether the ruminative process facilitates or hinders the
resolution of this ideal-real self-discrepancy Watkins (2008).
Moreover, the distinction between reflective rumination
(purposeful turning inwards with the intention of generating
possible solutions to the discrepancy) and brooding rumi-
nation (focusing purely on the causes, symptoms and con-
sequences of an illness) may further explain variable
outcomes in response to the ruminative process (Treynor
et al., 2003; Watkins and Teasdale, 2001).
Several measures of rumination exist, but each focuses on
a specific subcomponent of rumination, such as depression
and sadness (Siegle et al., 2004), neglecting to address the
multidimensional aspects of rumination, particularly in the
physical illness context (Luminet, 2004; Siegle et al., 2004).
The rumination subscale of the Responses Style Question-
naire (RRRSQ; Nolen-Hoeksema, 1991a), focusing on
rumination in response to depressed mood, has been most
commonly used. However, the RRRSQ does not capture the
degree to which individuals attempt to make sense of a
negative event, such as physical illness (Fritz, 1999; Horo-
witz et al., 1979), and does not incorporate the role of
positive (‘Thinking about my illness helps me understand its
cause’) and negative (‘I exhaust myself thinking about my
illness’) metacognitive beliefs about rumination likely to
influence psychological outcomes (Michael et al., 2007).
Given these limitations, the aim of the two current
studies was to develop a rumination scale for use specifi-
cally in the physical illness context. The Multidimensional
Rumination in Illness Scale (MRIS) is a brief, but com-
prehensive, self-report measure designed to assess rumi-
native tendencies in adults, specifically in the context of
physical illness. The scale accounts for diverse elements of
rumination in illness, incorporating subclasses of rumina-
tion, particularly brooding and reflection. The goal of
Study 1 was to select items to assess generic aspects of
rumination, such as the occurrence, intrusion, and con-
trollability of ruminative processes, and illness-specific
concerns, including attempts to understand the cause and
nature of illness. The MRIS accounts for positive and
negative beliefs about rumination in illness, since positive
beliefs about potential benefits, such as problem-solving,
have been linked to the initiation and maintenance of the
ruminative process, whereas negative beliefs in terms of
intrusiveness and controllability provide a pathway to
psychopathology (Michael et al., 2007; Papageorgiou and
Wells, 2003). Study 2 established the psychometric prop-
erties of a revised MRIS, through confirmatory factor
analysis and validity testing.
In developing the MRIS, limitations of existing scales
were addressed. Criterion contamination was addressed by
differentiating between rumination as a sign of depression
or sadness, versus rumination as a cognitive style—a dis-
tinction that has been blurred in existing rumination mea-
sures (Bagby et al., 2004, Roberts et al., 1998; Treynor
et al., 2003) [e.g., RRRSQ items such as ‘Think about how
sad you feel’ mirror the Beck Depression Inventory (BDI;
(Beck et al., 1961)) item, ‘I feel sad’ (Treynor et al.,
2003)]. Similar consideration was given to the presence of
items representing physical symptoms commonly experi-
enced in illness [e.g. an item from the RRRSQ, ‘Think
about your feelings of fatigue and achiness’].




Study participants (N = 185) who were 18 years or over and
diagnosed with a physical condition (i.e., acute/chronic ill-
ness and chronic pain conditions) completed the anonymous,
online survey in English (151 females, 34 males; median age
18–20 years) following informed consent. Participants
included (n = 68; 36.8 %) undergraduate psychology stu-
dents who received course credit towards a research partic-
ipation requirement, and 117 participants (63.2 %) recruited
online from psychological research websites. No incentives
for participation were provided to online participants. Ethics
approval was obtained from the relevant Australian institu-
tional Human Ethics Review Committee.
Measures
Demographic and clinical characteristics
Information about gender, age, level of education, current
physical and psychological diagnoses was collected. Par-
ticipants specified on which particular physical health
condition they would base their survey responses.
The Multidimensional Rumination in Illness Scale (MRIS)
Rumination in response to physical illness was measured
by the MRIS. A pool of 60 items was generated following
an extensive review of the rumination research literature
and existing rumination measures (Conway et al., 2000;
Horowitz et al., 1979; Nolen-Hoeksema and Morrow,
1991; Papageorgiou and Wells, 2001; Scott and McIntosh,
1999). Participants were presented with statements
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describing ways that people think about health conditions.
Each statement was rated according to frequency in rela-
tion to a current illness using a 5-point Likert-type scale
(‘0’ = ‘Not at all’ to 4 = ‘Almost always’) with item
scores were summed for a possible range of 0–240, with
higher scores representing a greater tendency towards
rumination. Individuals could indicate, via an open-ended
item, additional ways they thought about their illness.
Data analysis
Analyses were performed using SPSS statistical software,
Version 20 (SPSS Inc., 2011), with statistical significance
set at p \ .05. Data were screened for univariate outliers
and missing data. With no significant difference in MRIS
scores for the two sample sub-groups, descriptive statistics
described the sample demographic and clinical character-
istics. Exploratory principal axis factor analysis (PFA) was
selected to identify underlying common factors that explain
the covariances between individual items. PFA was
selected due to its recognition of the potential for error in
variables, thus providing unbiased and uninflated loadings
(Gorsuch, 1990). Factor structures were also analysed by




The demographic and clinical characteristics of the sample
are shown in Table 1. The mean MRIS score was 71.58
(SD = 39.55; range 0–191).
Table 1 Demographic and clinical characteristics of the sample for
Study 1 (N = 185)
Variable n M/% (SD) Range
Demographic factors
Gender (%)
Male 34 18.4 –
Female 151 82.8 –
Age range, in years (%)
18–20 63 34.1 –
21–30 38 20.5 –
31–40 20 10.8 –
41–50 22 11.9 –
51–60 26 14.1 –
61 and over 16 8.6 –
Education (%)
High school 19 10.3 –
Technical college 19 10.3 –
Undergraduate studies 95 51.4 –
Postgraduate studies 52 28.1 –
Location (%)
Australia 102 55.1 –
Canada 4 2.2 –
Finland 1 .5 –
France 1 .5 –
Spain 1 .5 –
United Kingdom 12 6.5 –
United States 64 34.6 –
Targeted condition (%)
Allergy 17 9.2 –
Arthritis 9 4.9 –
Autoimmune disease 16 8.6 –
Cancer 9 4.9 –
Cardiovascular disease 6 3.2 –
Chronic pain condition 4 2.2 –
Ear disorder 4 2.2 –
Endocrine disease 15 8.1
Eye disorder 3 1.6 –
Gastrointestinal disease 15 8.1 –
Genitourinary disease 4 2.2 –
Haematological disorder 8 3.8 –
Infectious disease 3 1.6 –
Spinal/neck condition 2 1.1 –
Musculo-skeletal disorder 11 5.9 –
Neurological disorder 18 9.7 –
Respiratory disease 25 13.5 –
Skin disorder 17 9.2 –
Comorbidities
No. of physical conditions 185 2.82 (3.56) 1–20
No. of psychological disorders 185 .45 (.77) 1–3
Psychological disorders (%)
None 128 69.2 –
Table 1 continued
Variable n M/% (SD) Range
Adjustment disorder 2 1.1 –
Anxiety 26 14.1 –
Depression 23 12.4 –
Eating disorder 1 .5 –
Health anxiety 3 1.6 –
Panic disorder 3 1.6 –
Phobia 2 1.1 –
Post-traumatic stress 2 1.1 –
Rumination
Total MRIS score 185 71.58 (39.55) 0–191
Instrumentality 185 11.95 (6.69) 0–32
Intrusion 185 8.82 (8.47) 0–33
Preventability 185 4.41 (3.87) 0–16
Brooding 185 11.98 (7.49) 0–36
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Principal axis factor analysis (PFA)
The factorability of the 60 MRIS items was examined. All
60 items correlated at least .3 with one or more items,
suggesting satisfactory factorability. The Kaiser–Meyer–
Olkin measure of sampling adequacy was .93, above the
recommended value of .6 (Tabachnick & Fidell, 2001), and
Bartlett’s test of sphericity was significant
(v(1770)
2 = 8728.98, p \ .01). Communalities were all
above .3, further confirming a common variance among
items. PFA was therefore conducted with all 60 items.
The initial analysis of 60 items suggested a nine-factor
solution (62.2 % variance), but the scree plot suggested
that only the first four factors would have an eigenvalue
above 1.0 (Spector, 1992). Parallel analysis (PA), consid-
ered to an effective, alternative procedure to confirm the
number of factors to retain (Hayton et al. 2004), also
suggested a four-factor solution. Consequently, five-, four-
and three-factor solutions were examined using Varimax
and Oblimin rotations of the factor-loading matrix. A four-
factor solution (explaining 54.3 % variance) was preferred
due to the insufficient number of primary loadings and
difficulty interpreting three- and five-factor solutions.
Oblique rotation was most appropriate, allowing obtained
factors to be inter-correlated.
The four factors were labeled: ‘Instrumentality’ (n = 8),
positive beliefs underlying the initiation and maintenance of
rumination (e.g. ‘Thinking about my illness helps me
understand its cause’); ‘Intrusion’ (n = 11), negative
dimensions including duration and lack of controllability
(e.g., ‘I can’t seem to control thinking about my illness);
‘Brooding’ (n = 9), content regarding the experience and
consequences of illness (e.g., ‘I think about how little I can do
to improve my situation’); and, ‘Preventability’ (n = 4),
making sense of illness and causality (e.g., ‘I think about
whether my illness is caused by a poor diet’).
In total 28 items were eliminated from the original list as
they failed to contribute to a simple factor structure, that is, to
meet minimum criteria of having a primary factor loading
C.5 with no cross-loading [.3, or represented redundant
items (inter-item correlation[.8). A PFA of the remaining 32
items with Varimax and Oblimin rotations was repeated,
with the four factors explaining 58.4 % of the variance
(Intrusion: 37.6 %, Instrumentality: 10.5 %, Preventability:
5.7 %, Brooding: 4.6 %). The Oblimin rotation provided the
best-defined factor structure and, with the exception of three
items with primary loadings [.45 [‘I believe that people
would think negatively about me if they realised how much I
think about my illness’ (.49), ‘I often feel the need to be by
myself to think about my illness’ (.45), ‘I think that trying
new things might be pointless’ (.48)], all retained items had
primary loadings[.5 with no cross-loadings[.3. The factor-
loading matrix is presented in Table 2, with a moderately
strong correlation between Intrusion and Preventability
noted, possibly reflecting the negative orientation of the
Preventability items.
The reliability coefficients for the whole scale (a = .94)
and the subscales were high: Brooding (a = .91), Instru-
mentality (a = .89), Intrusion (a = .94) and Preventability
(a = .87). Inter-item correlations ranged \ .8, with one
exception (r = .80) for items ‘Once I start thinking about
my illness, I find it hard to think of other things’ and ‘It
often requires a real effort to stop myself thinking about my
illness’, indicating minimal redundancy of items. The
factor correlation matrix is given in Table 3.
Additional areas of thinking in relation to illness were
highlighted by 58 participants (31.4 %). These were coded
separately by the researchers with an initial agreement rate
of 66.4 % and a disagreement rate of 33.6 %. Disagree-
ments were then discussed and resolved before codings
were finalised. These included side effects of treatment and
illness progression (n = 32), fatalism (illness as the work
of a higher power or the result of bad luck) (n = 4) and
isolation (n = 7).
Separate gender-specific factor analyses demonstrated
similar results to those obtained with the full sample, but
gender differences in MRIS total scores were evident
(men = 53.2, SD = 38.24; women = 75.72, SD = 38.77),
F(1,183) = 9.40, p \ .01. Gender differences were found
for the Brooding (men = 7.97, SD = 6.79; women =
12.89, SD = 7.36; F(1,183) = 12.72, p \ .01) and Instru-
mentality (men = 9.38, SD = 7.21; women = 12.53,
SD = 6.45; F(1, 183) = 6.32, p \ .05) subscales. The
number of physical illnesses reported was correlated with
MRIS total scores (r = .18, p \ .05) and the Brooding
(r = .22, p \ .01) and Instrumentality (r = .15, p \ .05)
subscales. The mean total MRIS score for those with a
comorbid psychological illness 88.91(SD = 40.59) was
higher than for individuals reporting a physical health con-
dition alone 63.86 (SD = 36.67), F(1,183) = 14.78,
p \ .01. These differences were also found in scores on the
Brooding, F(1,183) = 16.38, p \ .01, Instrumentality,
F(1,183) = 4.35, p \ .01, and Intrusion F(1,183) = 13.2,
p \ .01, subscales, with individuals reporting comorbid
psychological conditions scoring higher.




Eligibility criteria, participant recruitment and the ethics
approval process were identical to Study 1. In total 138
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females (mean age 36.55, SD = 15.08 years) and 25 males
(mean age 36.62, SD = 19.58 years) were recruited. Par-
ticipants (N = 163) included undergraduate psychology
students who received credit towards research participation
requirements (n = 44, 27.0 %) and individuals (n = 119,
73.0 %) recruited via psychological research websites. No
incentives for participation were provided to online par-
ticipants. All participants completed the Study 2 online
survey, with a subset (n = 23, 13.7 %) participating in a
repeat measurement of the MRIS after a 2-week period.
Table 2 Factor loadings and communalities based on a principal axis factor analysis with oblimin rotation for 32 items from the Multidi-
mensional Rumination in Illness Scale (MRIS) (N = 185)
Item Factor 1 Factor 2 Factor 3 Factor 4
intrusion instrumentality preventability brooding
Once I start thinking about my illness, I find it hard to think of other things .86 – – –
It often requires a real effort to stop myself thinking about my illness .86 – – –
Once I’m thinking about my illness, I can’t seem to do anything else .86 – – –
Sometimes I become lost in thought about my illness .82 – – –
Once started, I can spend considerable time thinking about my illness .75 – – –
I find myself unexpectedly thinking about my illness .68 – – –
I have trouble sleeping because of thinking about my illness .64 – – –
I can’t seem to control thinking about my illness .63 – – –
I exhaust myself thinking about the reasons for my illness .60 – – –
I believe that people would think negatively about me if they realised how much I think
about my illness
.49 – – –
I often feel the need to be by myself to think about my illness .45 – – –
Thinking helps me understand my illness – .79 – –
Thinking about my illness helps me work out what I need to do to manage it – .73 – –
Thinking about my illness helps me focus on what is important to me – .71 – –
Thinking about my illness is helpful in terms of protecting my health – .70 – –
Thinking about my illness helps me work out how to cope – .66 – –
Thinking about my illness helps me focus on what is still good in my life – .64 – –
Thinking about my illness helps me understand its cause – .59 – –
Thinking helps me work out what I need to do to regain a sense of ‘normality’ – .57 – –
I think about whether I could have avoided my illness if I’d taken better care of myself – – .87 –
I think about whether I might have done anything to cause my illness – – .85 –
I think about where things went wrong – – .67 –
I repeatedly go over possible causes for my illness – – .59 –
I think about the impact the illness will have on my life – – – .71
I think about the things I can no longer do – – – .70
I think about what life would have been like if I had not become ill – – – .70
I think about the things my illness might stop me doing – – – .69
I think about the seriousness of my illness – – – .63
I think about the goals I had that I may no longer be able to reach – – .62
I think about how little I can do to improve my situation – – – .59
I think that no matter what I do now, my life will never get better – – – .56
I think that trying new things may be pointless – – – .48
Only loadings [.3 are presented
Table 3 Factor correlation
matrix for the pilot test of the
Multidimensional Rumination
in Illness Scale
Intrusion Instrumentality Preventability Brooding
Intrusion 1.00 – – –
Instrumentality .21 1.00 – –
Searching for meaning .42 .17 1.00 –
Brooding .60 .25 .30 1.00
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Measures
Demographic and clinical characteristics
Demographic and medical history information was col-
lected for this study using the same items as for Study 1.
Multidimensional Rumination in Illness Scale (MRIS)
Rumination in response to illness was measured by the
revised 41-item MRIS following Study 1 piloting. The
revised scale, incorporating revisions to existing items to
improve readability and nine new items based on areas of
thinking in relation to illness highlighted by Study 1 par-
ticipants, demonstrated high internal consistency
(a = .96). The nine new items included ‘I think about how
little control I have over my illness’, ‘I think about whether
my illness may have been caused by stress’, ‘I think about
my symptoms, pain or the side effects of treatment’, ‘I
think about how isolated I feel by my illness’, ‘I think
about whether my illness is the result of poor diet or lack of
exercise’, ‘I think about the prospect of getting sicker or
even dying’, ‘I think about whether I’ve just been unlucky
to get this illness’, ‘I think about whether it was fate that I
got this illness’, and ‘I think about whether my illness was
determined by a higher power’. Two additional items,
supplementary to the main scale, were added to examine
the connection (‘Indicate the extent to which the thoughts
that you have been having about your illness have been
accompanied by feelings or emotions’) and orientation
(‘Overall, would you say these feelings or emotions tend to
be positively or negatively orientated?’) of emotion to
thoughts about illness.
Ruminative Responses Subscale of the Response Styles
Questionnaire (RRRSQ)
Proneness to depressive rumination was measured by the
23-item ruminative responses subscale of the RRSQ (No-
len-Hoeksema & Morrow, 1991) assessing responses to
negative mood focused on self, symptoms and conse-
quences of one’s mood. In past studies, the scale has
demonstrated good internal consistency (Nolen-Hoeksema
and Morrow, 1991), test–retest reliability (Nolen-Hoek-
sema et al., 1994) and validity (Just and Alloy, 1997). The
RRRSQ showed high internal consistency in the current
study (a = .94). This subscale offers the closest available
concurrent validation of the MRIS, hence it was predicted
that the MRIS total, Intrusion and Brooding subscales
would be correlated with the RRRSQ, with the Instru-
mentality subscale not correlated (divergent validity).
Intrusion Subscale of the Revised Impact of Events Scale
(IES-R-I)
Degree of intrusiveness of thoughts about a particular
distressing event over the past 7 days was assessed by the
7-item valid and reliable IES-R-I (Weiss and Marmar
1996) (a = .90 for the current study). It was anticipated
that IES-R-I scores would be positively correlated with
MRIS total, Intrusion and Brooding subscale scores (con-
current validity).
Depression, Anxiety and Stress Scale (DASS)
Depressive, anxious and stress symptomatology was
assessed with the DASS (Lovibond & Lovibond, 2002),
demonstrating adequate reliability and test–retest reliability
in past studies (Brown et al., 1997). For each 7-item sub-
scale, participants rated on a 4-point Likert-type scale
(0 = ‘Did not apply to me at all’ to 3 = ‘Applied to me
very much or most of the time’) the extent to which they
experienced each state over the previous week. All DASS
subscales showed high internal consistency in the current
study (Depression a = .89, Anxiety a = .76, Stress
a = .89). It was anticipated that all DASS subscales would
correlate with the MRIS total and subscale scores (except
Instrumentality - discriminant validity), although the rela-
tionships for the DASS-D scale would be expected to be
strongest given the link between rumination and depression
(Nolen-Hoeksema and Morrow, 1991; Nolen-Hoeksema
et al., 1994).
Positive Beliefs about Rumination Scale (PBRS)
Degree of belief about rumination as helpful was assessed
by the 9-item PBRS (Papageorgiou and Wells, 2001).
Participants rated their agreement with each item on a
4-point Likert-type scale (1 = ‘Do not agree’ to
4 = ‘Agree very much’). The PBRS has shown high
internal consistency, good test–retest reliability, conver-
gent and discriminant validity in past research (Luminet,
2004; Papageorgiou and Wells, 2001), demonstrating high
internal consistency in the current study (a = .94). It was
expected that the MRIS total and subscale scores would be
correlated with the PBRS.
Negative Beliefs about Rumination Scale (NBRS)
The 13-item Negative Beliefs about Rumination Scale
(NBRS; Papageorgiou et al., 2003) assessed negative
metacognitive beliefs about rumination regarding uncon-
trollability and harm associated with rumination practice,
including interpersonal and social consequences. In Study
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2, two items ‘Ruminating about my depression could make
me kill myself’ and ‘Ruminating can make me harm
myself’ were omitted due to ethical considerations related
to the online nature of the study. Each item is rated on a
4-point Likert-type scale (1 = ‘Do not agree’ to
5 = ‘Agree very much’). The NBRS has exhibited good
reliability and validity in past studies (Luminet, 2004), and
demonstrated high internal consistency in the current study
(a = .89). It was expected that the MRIS total, Intrusion
and Brooding subscale scores of would be correlated with
the NBRS (convergent validity).
Big Five Inventory-Neuroticism Scale (BFI-N)
The 8-item Big Five Inventory-Neuroticism Scale (BFI-N;
John et al., 2008; John and Srivastava, 1999) is a self-report
measure of neuroticism. Each item is rated on a 5-point
Likert-type scale (1 = ‘Disagree strongly’ to 5 = ‘Agree
strongly’). The BFI-N has shown good internal consistency
and test–retest reliability in earlier research (Hampson and
Goldberg, 2006; Rammstedt and John 2007), with a = .83
in the current study. As individuals who are higher in
neuroticism tend to ruminate more (Nolan et al., 1998;
Roberts et al., 1998) it was expected that scores on MRIS
total, Intrusion and Brooding subscales would be positively
correlated with the BFI-N (convergent validity).
Negative Affect SubScale (Positive and Negative Affect
Scale) (PANAS-N; Watson et al., 1988)
The 10-item Negative Affect subscale of the PANAS
measured range and degree of negative affective arousal.
Sample negative emotions include ‘distressed’, ‘upset’ and
‘guilty’, rated on a 5-point response scale (1 = ‘Very
slightly’ or not at all to 5 = ‘Extremely’). The PANAS has
exhibited excellent internal consistency and has demon-
strated convergent, discriminant, and predictive validity
(Waikar and Craske 1997; Watson and Walker, 1996). The
PANAS-N showed high internal consistency in the current
study (a = .93). It was anticipated that PANAS-N scores
should be positively correlated with the MRIS and with
Brooding and Intrusion subscale scores given the reciprocal
relation between rumination and negative affect (conver-
gent validity).
Penn State Worry Questionnaire (PSWQ; Meyer et al.,
1990)
The 16-item valid and reliable PSWQ (Molina and Borkovec,
1994; Meyer et al., 1990) assessed worry. Internal consistency
in the current study was high (a = .95). The PSWQ was
expected to be correlated with the MRIS, Intrusion, Brooding
subscales but to a lesser degree than the MRIS correlation with
the RRRSQ, demonstrating discriminant validity.
Data analysis
Analyses were performed using SPSS statistical software,
Version 20 (SPSS Inc., 2011), with statistical significance
set at p \ .05. These data were initially screened for uni-
variate outliers, missing data and violations to the
assumptions of multivariate analysis. No data transforma-
tions were required. Descriptive statistics described the
demographic and clinical characteristics of the sample. A
confirmatory factor analysis was conducted through struc-
tured equation modeling with Amos software, Version 20
(SPSS Inc., 2011). Maximum Likelihood Estimation
(MLE) was used to estimate a revised three-factor model
(Intrusion, Instrumentality and Brooding). A decision to
test a revised model with Preventability and Intrusion
factors collapsed was made on the basis of the high cor-
relation demonstrated between these factors in Study 1, and
in the context of additional items generated following
Study 1. Individual items were parceled on the basis of
unidimensional facets within each factor (Holt, 2004), as
parcels are more likely to be normally distributed, meeting
the assumptions of MLE methods (Nasser and Wisenbaker,
2003). This procedure may result in lower goodness of fit
indices, particularly in smaller sample sizes, as for this




Demographic and clinical characteristics of the sample are
shown in Table 4. The mean MRIS score was 52.75
(SD = 27.62; range 3–129). The mean score for the sup-
plementary item ‘amount of time thoughts about illness
were accompanied by emotions’ was 2.95 (SD = 1.16),
with higher scores representing a greater presence of
emotions when thinking about illness. The mean score for
the supplementary item ‘positivity versus negativity of
those emotions’ was 2.42 (SD = 1.09), higher scores rep-
resenting more positive emotions.
Gender, number of physical illnesses and comorbid
psychological conditions
The mean total MRIS score for men was lower (46.52,
SD = 20.39) than for women (53.88, SD = 28.65), but not
significantly different, F(1,161) = 1.51, p\ .22. Similarly,
there were no significant gender differences across any of the
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MRIS subscales. There was no significant correlation between
the number of physical illnesses reported and MRIS total scores
or the MRIS subscale scores. However, the mean total MRIS
score for those reporting on more severe physical conditions
(59.64, SD = 26.34) was higher than those reporting on less
severe or chronic physical conditions (49.96, SD = 27.75),
F(1,161) = 4.19, p\ .05. The mean total MRIS score for
those without any comorbid psychological conditions (47.30;
SD = 26.46) was lower than for those with comorbid psy-
chological illness (65.81, SD = 26.16), F(1,161) = 16.69,
p\ .01. These differences were replicated in scores on the
Brooding, F(1,161) = 19.04, p\ .01, and Intrusion,
F(1,161) = 12.02, p\ .01, subscales, with individuals
reporting comorbid psychological conditions scoring higher.
Confirmatory factor analysis
A confirmatory factor analysis (CFA), using a MLE solu-
tion was conducted to test a revised 3-factor MRIS struc-
ture (refer to Fig. 1 for the conceptual model tested). The
model showed good fit with these data ([v2(df = 17,
N = 163) = 25.81, p = .08, GFI = .96, CFI = .99,
RMSEA = .06]. All parcels loadings on their respective
factor exceeded .79. Table 5 specifies the correlations
between the three factors.
Reliability testing
The full-scale MRIS and subscales showed high internal
consistency in the current study: full scale (a = .96), Intru-
sion (a = .94), Brooding (a = .92), and Instrumentality
(a = .86). Mean MRIS total scores at testing and retesting
Table 4 Demographic and clinical characteristics of the sample for
Study 2 (N = 163)
Variable n M/% (SD) Range
Demographic factors
Gender (%)
Male 25 15.3 –
Female 138 84.7 –
Age (years) 163 37.02 (15.81) 18–75
Education, level completed (%)
High School 44 27.0 –
Technical College 15 9.2 –
Undergraduate studies 47 28.8 –
Postgraduate studies 57 35.0 –
Location (%)
Australia 94 57.7 –
Austria 1 .6 –
Belgium 1 .6 –
Canada 2 1.2 –
Finland 8 4.9 –
Italy 1 .6 –
Norway 1 .6 –
Singapore 1 .6 –
United Kingdom 13 8.0 –
United States 41 25.2 –
Physical health targeted condition (%)
Allergy 12 7.4 –
Arthritis 15 9.2 –
Autoimmune disorder 11 6.7 –
Cancer 31 19.0 –
Cardiovascular disorder 4 2.5 –
Endocrine disorder 10 6.1 –
Eye disorder 4 2.5 –
Gastrointestinal disorder 10 6.0 –
Haematological disorder 8 4.9 –
Infectious disorder 6 3.7 –
Musculo-skeletal disorder 28 17.2 –
Neurological disorder 9 5.5 –
Respiratory disorder 6 3.7 –
Skin disorder 3 1.8 –
Other 6 3.7 –
Psychological disorders (%)
None reported 108 66.3 –
Adjustment disorder 1 .6 –
Anxiety disorder 13 8.0 –
Bipolar disorder 3 1.8 –
Depression 23 14.1 –
Eating disorder 5 3.1 –
Health anxiety 1 .6 –
Obsessive–compulsive 4 2.5 –
Panic disorder 3 1.8 –
Phobia disorder 3 1.8 –
Table 4 continued
Variable n M/% (SD) Range
Post-traumatic stress 6 3.7 –
Social phobia 2 1.2 –
Substance disorder 1 .6 –
Comorbidities
No. of physical conditions 141 3.12 (3.21) 1–15
No. of psychological disorders 48 1.88 (1.73) 1–7
Measures
MRIS score 163 52.75 (27.62) 3–129
RRRSQ score 157 20.16 (12.47) 0–57
IES-R-I score 155 7.52 (5.84) 0–28
PBRS score 152 16.42 (6.65) 9–36
NBRS score 154 16.90 (6.26) 11–41
PSWQ score 153 48.42 (15.58) 17–77
PANAS-NA score 153 16.18 (7.49) 10–43
BIG5 N score 154 23.03 (6.61) 8–38
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were 51.61 (SD = 30.86) and 47.26 (SD = 33.23), respec-
tively. A repeated measures t test indicated that mean MRIS
scores did not change over the 2 weeks period, t(22) = .89,
p [ 05. The Pearson product-moment coefficient,
r(23) = .57, p \ .01, demonstrated moderate MRIS test–
retest reliability. However, this is likely to reflect the fact that
the test-reliability data is based on a student sample that
typically reported less severe, less chronic illnesses includ-
ing tonsillitis and influenza, and may also reflect the rela-
tively short-lived nature of the illness on which responses
were made. Higher reliability coefficients might reasonably
be expected in the context of more severe illnesses (such as
cancer and cardiovascular disease).
Validation testing
Inter-correlations among the MRIS, its three factors
(Intrusion, Instrumentality, and Brooding) and other scales
selected for comparison are presented in Table 6. The
Fig. 1 Path diagrams for the confirmatory factor analysis of the
Multidimensional Rumination in Illness Scale. Note INTRP1,
INTRP2, INTRP3 item parcels for intrusion; BROODP1, BROODP2,
BROODP3, items parcels for brooding; INSTRP1, INSTRP2, item
parcels for instrumentality
Table 5 Factor correlation matrix for the validation testing of the
Multidimensional Rumination in Illness Scale (MRIS)
Intrusion Instrumentality Brooding
Intrusion 1.00 – –
Instrumentality .42 1.00 –
Brooding .78 .37 1.00
Correlations are significant at the p \ .01 level
Table 6 Correlations for the MRIS and other measures
Scale/dimension Mean (SD) n R








































RRRSQ Ruminative Responses Subscale of the Response Styles
Questionnaire; IES-R-I Intrusion Subscale of the Revised Impact of
Events Scale; PBRS Positive Beliefs About Rumination Scale; NBRS
Negative Beliefs About Rumination Scale; DASS Depression, Anxiety
and Stress Scale; BIG-5-N Big Five Inventory, Neuroticism Subscale;
PANAS-N Negative subscale of the Positive and Negative Affect
Scale; PSWQ Penn State Worry Questionnaire; *Correlations are
significant at the p \ .05 level **Correlations are significant at the
p \ .01 level; fluctuations in sample size for subscales of the same
measure (e.g. DASS) or for different measures are due to missing
values. For all measures, higher scores reflect more of the underlying
construct
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MRIS correlated positively and significantly with all
measures. Demonstrating good concurrent validity in the
current sample, the MRIS was most strongly related with
the RRSSQ and IES-R-I measures of the same construct.
The MRIS also was strongly correlated with the PBRS and,
to a lesser extent, the NBRS. As expected, the MRIS dis-
played good convergent validity, being significantly cor-
related with the measure of neuroticism, the BFI-N, the
PANAS-N and measures of depression, anxiety and stress
(DASS-D; DASS-A; DASS-S) in the current study. The
MRIS also demonstrated divergent validity in the current
sample. As predicted, there was a greater correlation
between the MRIS and RRRSQ than between the MRIS
and the PSWQ, demonstrating that while rumination may
indeed be related, it is not identical to worry.
General discussion: Studies 1 and 2
This paper describes the development, reliability and val-
idation testing of the MRIS, a measure of rumination
suitable for use in the context of a physical health condi-
tion. Rumination as a construct represents a broad class of
thoughts, one that has been difficult to measure with a
single inventory (Siegle et al., 2004). While the MRIS has
been developed to measure a specific subset of rumination,
it is intended to incorporate the multiple facets of rumi-
nation that are particularly relevant in the physical illness
context.
Exploratory factor analysis of the initial 60 items of the
MRIS demonstrated a clearly interpretable factor structure
for a final selection of 32 items, with distinct factors
reflecting both adaptive (Instrumentality) and less adaptive
(Intrusion, Brooding, Preventability) forms of rumination.
Preventability was found to be highly correlated with
Intrusion, reflecting the negative orientation of items
relating to preventability, representing concern about what
could have been done to avoid the illness. This kind of
cognitive content is commonly found in intrusive thoughts
following trauma (Nightingale et al., 2010) and therefore,
consistent with the addition of similar items to the revised
scale, the Intrusion and Preventability factors were col-
lapsed for Study 2. In Study 2, the revised three-factor
model of rumination was corroborated with confirmatory
factor analysis.
While the three MRIS dimensions were consistent with
previously identified domains in prior rumination studies
(Fritz, 1999; Papageorgiou and Wells, 2001; Treynor et al.,
2003), the MRIS differs from other rumination measures in
that those previously identified domains are combined into
a single measure with a specific application to the context
of illness. In this way, while the ‘Brooding’ dimension
mirrors that of scales such as the RRRSQ to capture a sense
of gloomy focus on symptoms and feelings, the MRIS
dimension also extends to thoughts about the consequences
and limitations that may follow an illness diagnosis. The
‘Instrumentality’ dimension combines elements of both the
‘Reflection’ domain of the revised RRRSQ (Treynor et al.,
2003), and ‘Instrumentality’ dimension defined by Fritz
(1999) as rumination on the ‘practical implications of an
event’ (p. 105) but also incorporates positive meta-cogni-
tions about rumination that may explain the initiation and
maintenance of the rumination process (Papageorgiou and
Wells, 2001). These two MRIS subscales are arguably
more robust than those in the revised RRRSQ (Treynor
et al., 2003), consisting of a greater number of items and
with a higher demonstrated reliability of each subscale.
Finally, the ‘Intrusion’ dimension integrates the intensity
and repetitiveness of rumination with the negative meta-
cognition on rumination outlined by Papageorgiou et al.
(2003) to include interpersonal consequences of rumina-
tion, of particular importance as the illness experience can
result in isolation (Fawzy et al., 2001). It also incorporates
attempts at understanding one’s distress, content that is
frequently experienced as intrusive subsequent to trauma
(Nightingale et al., 2010).
The observed gender difference in MRIS scores from
Study 1, with greater rumination reported among females,
reflects previously documented gender differences (Nolen-
Hoeksema and Jackson, 2001; Nolen-Hoeksema et al.,
1999). Nolen-Hoeksema (1991b) reported that females are
more likely to adopt self-focused rumination as a coping
strategy, a strategy that has been shown to moderate the
gender difference in depression in some studies (Nolen-
Hoeksema et al., 1999; Roberts et al., 1998). Although the
gender difference was not observed in Study 2, this most
likely reflects the under-representation of males in the
Study 2 sample.
Initial examination of the MRIS psychometric properties
demonstrated excellent internal consistency for the entire
scale and each obtained rumination factor, as well as
moderate test–retest reliability over a two-week period
within the context of the current sample. The MRIS and its
factors evidenced good concurrent, convergent and dis-
criminant validity in this sample. Concurrent validity was
demonstrated by the strong, positive relationship between
the MRIS and other measures of rumination. Importantly,
the MRIS was also positively correlated with constructs that
are theoretically related to rumination, including positive
and negative metacognitive beliefs. Taken together, these
results support the psychometric properties and validity of
the MRIS among individuals diagnosed with an illness.
The current research is subject to a number of limita-
tions. Some dispute exists over the most appropriate sam-
ple size with which factor analysis can be undertaken
(Tabachnick and Fidell, 2001; Gorsuch, 1983). However,
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this was addressed in the current CFA by parceling items
for analysis, an appropriate approach for use with smaller
sample sizes (Floyd and Widaman, 1995; Kishton and
Widaman 1994). A further limitation relates to heteroge-
neity as the samples were based on adults diagnosed with a
variety of physical health conditions, which may system-
atically influence responses based on different health
experiences; although, conversely, the heterogeneity of the
sample may arguably also be a strength of the study, as the
MRIS was validated for use across a wide range of physical
conditions. The sample is also further limited in respect to
demographic characteristics, with an under-representation
of males and an over-representation of individuals with
higher levels of education. While any association between
rumination and education has yet to be determined, a link
between gender and rumination has been indicated as
underlying gender differences in depression (Nolen-
Hoeksema and Jackson, 2001; Nolen-Hoeksema et al.,
1999).
Additionally, no consideration was given to the time
since diagnosis of the physical health conditions in this
study. Finally, the preliminary support for the reliability
and validity of the MRIS in this study comes from cross-
sectional research and further longitudinal research is
needed to demonstrate the utility of the MRIS over time.
In summation, the findings from the two studies suggest
the MRIS exhibits excellent reliability and validity in the
context of physical illness. The MRIS measures three
dimensions of rumination including Intrusion, Brooding,
and Instrumentality. This multidimensional nature of the
MRIS will facilitate examination of how individual sub-
components of rumination relate to specific psychological
outcomes in illness, for while it has been argued that
rumination represents an increased vulnerability to psy-
chological distress; it has also been linked to positive
outcomes in cancer in the form of post-traumatic growth
(Calhoun et al., 2000). Expanding such research to various
illness populations will contribute to further understanding
of how various groups perceive and process a health threat.
Finally, the MRIS has the scope to have utility as a clinical
instrument to identify individuals who may have a dispo-
sitional tendency to rumination the context of an illness
diagnosis and therefore be more vulnerable to developing
depression and anxiety, allowing timely provision of
appropriate interventions.
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